Levon Hangover - VBINothing like doing a large share offering at the bottom!!!!PC. VBI Vaccines Announces Pricing of $35 Million Public Offering CAMBRIDGE, Mass. (September 19, 2019) VBI Vaccines Inc. (Nasdaq: VBIV) (VBI or the Company), a commercialstage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced the pricing of its previously announced underwritten public offering of 70,000,000 common shares, at a public offering price of US$0.50 per share. VBI also granted the underwriters a 30-day option to purchase up to an additional 10,500,000 common shares at US$0.50 per share. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other estimated offering expenses, are expected to be approximately US$35 million, excluding any exercise of the underwriters option to purchase additional shares. The offering is expected to close on or about September 23, 2019, subject to satisfaction of customary closing conditions.